Device Authority expands enterprise reach through IoT security partnership

Tern plc

Device Authority has strengthened its enterprise positioning through a strategic partnership with Xalient, a provider of identity-led cybersecurity services and managed solutions. The collaboration will see Xalient integrate Device Authority’s KeyScaler platform into its IoT security offering, with the aim of helping enterprise customers protect connected devices across complex IT, IoT and operational technology environments.

This places Device Authority’s technology within a managed security model that is designed for large organisations facing rising operational, regulatory and cyber risk. As connected devices become more embedded in sectors such as energy, utilities, manufacturing, healthcare and critical infrastructure, enterprises are under pressure to secure assets that are often distributed, long-lived and difficult to manage through traditional security tools.

The partnership addresses a practical challenge for customers: manual approaches to device identity, credential management and access control are increasingly difficult to scale. In large deployments, unmanaged or poorly governed devices can create visibility gaps, compliance issues and operational exposure. Device Authority’s KeyScaler platform is designed to automate identity lifecycle management for IoT and OT devices, from secure onboarding and credential provisioning through to certificate rotation, decommissioning and policy-driven access control.

Xalient’s role adds an important route-to-market dimension. By delivering the joint capability through its managed “as-a-service” security model, Xalient can support customers that want to improve IoT and OT security without adding complexity to internal teams.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Evidence-based care pathways create clearer routes to adoption

Evidence-based care pathways can reduce delays, improve treatment consistency and support the adoption of new therapies.

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

Tern plc raises £450,000 in share placing ahead of AIM admission

Tern plc has raised £450,000 through a placing and outlined expected admission timing and updated voting rights.

AI search makes message measurement a healthcare priority

As AI changes search, healthcare companies need to know whether their messages are being seen, understood and represented correctly.

Search